摘要
A series of 2-Aryl-4-Bis-amide Imidazoles (ABAI-1 to 30) were designed as anti-inflammatory agents. These compounds were synthesized and evaluated for the in vitro anti-inflammatory activities (inhibition of NO production and release of inflammatory cytokines). Several compounds effectively inhibited NO production in lipopolysaccharide (LPS) induced RAW264.7 cells. Among them, ABAI-30 exhibited the highest NO-inhibitory effect (inhibition rate of 87% at 20 mu M). The anti-inflammatory mechanism of ABAI-30 was examined and found to be inhibiting the TLR4-pp65 and NLRP3-caspase-1 signaling pathway, thus leading to the down regulation of IL6, IL-113 and TNF alpha at both transcriptional and translational levels. Importantly, ABAI-30 demonstrated high in vivo anti-inflammatory efficacy in a dextran sulfate sodium (DSS)-induced colitis mouse model without causing obvious toxicity. Collectively, our study provides a potent anti-inflammatory agent, which deserves further investigation as a novel therapeutic candidate for treating inflammatory bowel diseases.
学科与关键词
- Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agentsChen, Jingxuan; Li, Ling; Liu, Jin; Yuan, Sijie; Liao, Wenzhen; Slominski, Andrzej T.; Li, Wei; Zmijewski, Michal A.; Chen, JianjunEuropean Journal of Medicinal Chemistry, 2021, 220: 113468.被引 7
- Imidazopyrazines as New Anti-inflammatory Agents: Discovery and Biological Activity Research in vitro and in vivoLai, Qingfu; Li, Tong; Zhang, Fuli; Li, Ming; Mei, Qinghua*; Ye, Lianbao*ChemistrySelect, 2022, 7(15): e202104531.被引 1
- Anemoside B4 protects against chronic relapsing colitis in mice by modulating inflammatory response, colonic transcriptome and the gut microbiotaHan, Qian; Deng, Li-rong; Zou, Min; Tang, Hua-zheng; Huang, Chang-yin; Chen, Fang-jun; Tomlinson, Brian; Li, Yan-hong*PHYTOMEDICINE, 2022, 106: 154416.被引 6
